Russia Archives -

Market Access/ News/ News

EMA starts rolling review of Sputnik V COVID vaccine

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, ema, EU, Russia, Sputnik V 0 Comment

With EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the

EMA starts rolling review of Sputnik V COVID vaccine

https://pharmaphorum.com/news/ema-starts-rolling-review-of-sputnik-v-covid-vaccine/

News/ News/ R&D

Sputnik V data in Lancet should end “fake news” on its efficacy, says RDIF

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, RDIF, Russia, Sputnik V 0 Comment

The publication of data backing Russia’s COVID-19 vaccine Sputnik V in a peer review journal should bring a

Sputnik V data in Lancet should end “fake news” on its efficacy, says RDIF

https://pharmaphorum.com/news/sputnik-v-data-in-lancet-should-end-fake-news-on-its-efficacy-says-rdif/

News/ News/ Sales and Marketing

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’

Phil Taylor AstraZeneca, AZD1222, coronavirus, coronavirus vaccine, COVID-19, Oxford University, Russia, Sputnik V 0 Comment

The developer of Russia’s COVID-19 vaccine Sputnik V has pledged to make it available for less than $10

Russian Sputnik COVID-19 vaccine ‘will cost less than $10 a dose’

https://pharmaphorum.com/news/russian-sputnik-covid-19-vaccine-will-cost-less-than-10-a-dose/

News/ News/ R&D/ Top stories

Russia claims 92% efficacy for Sputnik COVID-19 shot

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, Russia, Sputnik V 0 Comment

In the second positive piece of COVID-19 vaccine news in a week, Russia’s Sputnik V candidate has been

Russia claims 92% efficacy for Sputnik COVID-19 shot

https://pharmaphorum.com/news/russia-claims-92-efficacy-for-sputnik-covid-19-shot/

Market Access/ News/ News

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, Russia, Sputnik V, World Health Organisation 0 Comment

Russia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see

Russia’s COVID-19 vaccine filed with WHO, as MHRA reviews Moderna shot

https://pharmaphorum.com/market-access-2/russias-sputnik-v-covid-19-shot-filed-with-who/

Coronavirus vaccine: how pharma is picking up the pace

News/ News/ R&D

Sanofi preps trials of second COVID-19 shot, as Russia approves another

Phil Taylor China, coronavirus, coronavirus vaccine, COVID-19, Russia, Sanofi, Translate Bio 0 Comment

Sanofi will shortly start human trials of a second coronavirus vaccine, developed with US biotech Translate Bio, after

Sanofi preps trials of second COVID-19 shot, as Russia approves another

https://pharmaphorum.com/news/sanofi-preps-trials-of-second-covid-19-shot-as-russia-approves-another/

News/ News/ Sales and Marketing

Takeda nets $660m from product selloff to Germany’s Stada

Phil Taylor emerging markets, generic, OTC, Russia, Stada, Takeda 0 Comment

Takeda has divested another block of products it views as lying outside its main focus, selling various drugs

Takeda nets $660m from product selloff to Germany’s Stada

https://pharmaphorum.com/news/takeda-nets-660m-from-product-selloff-to-germanys-stada/

Articles/ Healthcare/ Pharma Market Access/ Views and analysis

Six factors shaping healthcare in emerging markets

Linda Banks China, emerging markets, healthcare, India, market access, patients, Russia 0 Comment

The factors shaping the healthcare landscape in emerging markets.

Six factors shaping healthcare in emerging markets

https://pharmaphorum.com/views-and-analysis/healthcare-emerging-markets/

Trending

Russia

Login